000 02161cam a2200349 a 4500
003 EG-GiCUC
005 20250223032317.0
008 190616s2018 ua f m 000 0 eng d
040 _aEG-GiCUC
_beng
_cEG-GiCUC
041 0 _aeng
049 _aDeposite
097 _aPh.D
099 _aCai01.11.19.Ph.D.2018.As.A
100 0 _aAshgan Mohamed Zayed
245 1 0 _aAssessment of the potential effect of Epstein-Barr Virus concomitant infection on the response to Interferon-Ribavirin therapy among chronic Hepatitis C Virus infected patients /
_cAshgan Mohamed Zayed ; Supervised Abdelfattah Mohammed Attia , Nadia Mohamed Madany , Lamiaa Abdelfattah Ahmed Madkour
246 1 5 _aدراسة مدى تأثير الإصابة بفيروس ابشتين- بار على استجابة مرضى الالتهاب الكبدى الفيروسى المزمن (سي) للعلاج بالانترفيرون
260 _aCairo :
_bAshgan Mohamed Zayed ,
_c2018
300 _a82 P. ;
_c25cm
502 _aThesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Microbiology and Immunology
520 _aBackground and aim: Epstein-Barr Virus (EBV) is one of the most ubiquitous viruses that canse liver pathology. presumably, a co-infection of EBV and hepatitis C Virus (EBV) may impact the prognosis of HCV-infected patiets. hence, in this study we endeavored to estimate the effect of EBV infection on the response to treatment with interferon and ribavirin therapy in chronic HCV patients. Methodes: thestaudy was conducted on 84 chronic HCV patients and 16 control subjects. viral loads were assessed using reverse transcription polymerase chain reaction, while anti-EBV IgM levels were determined by ELISA
530 _aIssued also as CD
653 4 _aEpstein-Barr Virus
653 4 _aHepatitis C Virus
653 4 _aInterferon
700 0 _aAbdelfattah Mohammed Attia ,
_eSupervisor
700 0 _aLamiaa Abdelfattah Ahmed Madkour ,
_eSupervisor
700 0 _aNadia Mohamed Madany ,
_eSupervisor
856 _uhttp://172.23.153.220/th.pdf
905 _aAsmaa
_eCataloger
905 _aNazla
_eRevisor
942 _2ddc
_cTH
999 _c72470
_d72470